GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Longduoduo Co Ltd (OTCPK:LDDD) » Definitions » Net-Net Working Capital

Longduoduo Co (Longduoduo Co) Net-Net Working Capital : $-0.01 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Longduoduo Co Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Longduoduo Co's Net-Net Working Capital for the quarter that ended in Mar. 2024 was $-0.01.

The industry rank for Longduoduo Co's Net-Net Working Capital or its related term are showing as below:

LDDD's Price-to-Net-Net-Working-Capital is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 5.375
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Longduoduo Co Net-Net Working Capital Historical Data

The historical data trend for Longduoduo Co's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longduoduo Co Net-Net Working Capital Chart

Longduoduo Co Annual Data
Trend Jun21 Jun22 Jun23
Net-Net Working Capital
-0.02 -0.04 -0.03

Longduoduo Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.03 -0.03 -0.02 -0.01

Competitive Comparison of Longduoduo Co's Net-Net Working Capital

For the Diagnostics & Research subindustry, Longduoduo Co's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longduoduo Co's Price-to-Net-Net-Working-Capital Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Longduoduo Co's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Longduoduo Co's Price-to-Net-Net-Working-Capital falls into.



Longduoduo Co Net-Net Working Capital Calculation

Longduoduo Co's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Jun. 2023 is calculated as

Net-Net Working Capital(A: Jun. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.137+0.75 * 0+0.5 * 0.001-2.053
-0--0.029)/30.005
=-0.03

Longduoduo Co's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2024 is calculated as

Net-Net Working Capital(Q: Mar. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.883+0.75 * 0+0.5 * 0-2.122
-0-0.022)/30.005
=-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Longduoduo Co  (OTCPK:LDDD) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Longduoduo Co Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Longduoduo Co's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Longduoduo Co (Longduoduo Co) Business Description

Traded in Other Exchanges
N/A
Address
Ordos Street, 419, Floor 4, Comprehensive Building, Second Light Hospital, Yuquan District, Inner Mongolia, Hohhot, CHN, 010000
Longduoduo Co Ltd through its operating subsidiaries engaged in the business of providing preventive healthcare solutions. It provides a wide range of comprehensive preventive healthcare services including disease screening, healthcare treatments, healthcare products, and other services. The company mainly focuses on the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. The company's revenues are generated from its customers in the People's Republic of China.

Longduoduo Co (Longduoduo Co) Headlines

No Headlines